• Users Online: 474
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Adverse drug reactions in tuberculosis patients due to directly observed treatment strategy therapy: Experience at an outpatient clinic of a teaching hospital in the city of Imphal, Manipur, India

Sinha Kumarjit, Marak Izora Trudy R, Singh W Asoka

Year : 2013| Volume: 1| Issue : 2 | Page no: 50-53

   This article has been cited by
1 Analysis of Adverse Drug Reactions associated with Anti-tubercular drugs – A Retrospective Study
Dharini Boopathi, Akshatha J S, Uma Buggi, Hema Siva, Arun K P, Deepalakshmi Mani
Research Journal of Pharmacy and Technology. 2022; : 1483
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of patient’s experiences with daily DOTS
Akshaya Moorthy,Surabhi Jaggi,Kranti Garg,Mandeep Kaur Sodhi,Deepak Aggarwal,Jagdish Chander
Indian Journal of Tuberculosis. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Symptom experience of adverse drug reaction among male and female patients with newly diagnosed pulmonary tuberculosis in Thailand
Apichaya Thontham, Rapin Polsook
Belitung Nursing Journal. 2021; 7(3): 195
[Pubmed]  [Google Scholar] [DOI]
4 Adverse drug reaction profile of daily regimen antituberculosis treatment
KN Hari Sankar,Kevin Roch,Doyce Jom,DhanyaS Palappallil,Prabitha Panattil,RajaniK Sankaranarayanan
Perspectives in Clinical Research. 2021; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
5 Spectrum of cutaneous adverse drug reactions to anti-tubercular drugs and safe therapy after re-challenge - A retrospective study
ReenaK Sharma, GhanshyamK Verma, GitaRam Tegta, Samriti Sood, Renu Rattan, Mudita Gupta
Indian Dermatology Online Journal. 2020; 11(2): 177
[Pubmed]  [Google Scholar] [DOI]
6 ‘Have we missed reporting adverse drug reactions under Revised National TB Control Programme?’ - A mixed method study in Bengaluru, India
Lalitha Krishnappa,Suman Gadicherla,Priyadarshini C,Anuradha HV,Shivaraj NS,Poonam R. Naik,Arundhati Das,Somashekar N,Sharath Burugina Nagaraja
Indian Journal of Tuberculosis. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Haematological profiles after Intensive phase of Anti Koch Treatment with special emphasis on bone marrow changes
Debjani Basu,Saumitra Biswas,Rudranarayan Ray
Indian Journal of Tuberculosis. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
Abhijeet Singh,Rajendra Prasad,Viswesvaran Balasubramanian,Nikhil Gupta,Pawan Gupta
Clinical Epidemiology and Global Health. 2015; 3: S80
[Pubmed]  [Google Scholar] [DOI]
Nemagouda S
Journal of Evolution of Medical and Dental Sciences. 2014; 3(19): 5255
[Pubmed]  [Google Scholar] [DOI]


Read this article